Skip to content
← Back to this collection

PUBLICATIONS · 8487048

Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1993 May
First author
Pullen J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Pullen J
      type
      Author
    2. name
      Boyett J
      type
      Author
    3. name
      Shuster J
      type
      Author
    4. name
      Crist W
      type
      Author
    5. name
      Land V
      type
      Author
    6. name
      Frankel L
      type
      Author
    7. name
      Iyer R
      type
      Author
    8. name
      Backstrom L
      type
      Author
    9. name
      van Eys J
      type
      Author
    10. name
      Harris M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Pullen J
      type
      Author
    2. name
      Boyett J
      type
      Author
    3. name
      Shuster J
      type
      Author
    4. name
      Crist W
      type
      Author
    5. name
      Land V
      type
      Author
    6. name
      Frankel L
      type
      Author
    7. name
      Iyer R
      type
      Author
    8. name
      Backstrom L
      type
      Author
    9. name
      van Eys J
      type
      Author
    10. name
      Harris M
      type
      Author
    bibliography ids
    1. nci-bib-e8e50fb313b799fe5b394219
    book metadata
    content sha256
    44539e0d3cb4f25a7bf8418419eb4448abcd747a75d595b335342f7e60342d17
    document type
    citation
    dois
    1. 10.1200/JCO.1993.11.5.839
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:8487048
    immutable id
    pubmed:8487048@44539e0d3cb4f25a7bf8418419eb4448abcd747a75d595b335342f7e60342d17
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    5
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    839-49
    volume
    11
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      8487048
      provenance
      batch id
      6de860041cedd40f623b
      provider
      NCBI PubMed ESummary
      record sha256
      90818b3e9c0ba9d2aca74f04354d98cafa1afb80c5077f45dad892e856c06749
      response sha256
      f46103bbddb69bd5f2ea5fd2e8d9cab75a19eeb01ce2a0d1f98b4d456a872039
      retrieved at
      2026-09-09T23:45:23.163950+00:00
      publication date
      display
      1993 May
      precision
      month
      year
      1993
      publication types
      1. Clinical Trial
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      6. Research Support, Non-U.S. Gov't
      7. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/8487048/
      title
      Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.

      Preserved source evidence · Not medical advice